{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T09:36:48Z","timestamp":1768642608742,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.clgc.2012.08.009","type":"journal-article","created":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T14:23:56Z","timestamp":1350483836000},"page":"39-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Upper Urinary Tract Transitional Cell Carcinoma: Is There a Best?"],"prefix":"10.1016","volume":"11","author":[{"given":"Levent Mert","family":"Gunay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bulent","family":"Akdogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artan","family":"Koni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kubilay","family":"Inci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cenk Yucel","family":"Bilen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haluk","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2012.08.009_bib1","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/j.1464-410X.2008.07438.x","article-title":"Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract","volume":"101","author":"Novara","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2012.08.009_bib2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.urolonc.2009.06.003","article-title":"Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance","volume":"29","author":"Az\u00e9mar","year":"2009","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2012.08.009_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0022-5347(06)00511-8","article-title":"Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma","volume":"176","author":"Akdogan","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2012.08.009_bib4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0090-4295(99)00563-4","article-title":"Risk factors for the development of bladder cancer after upper tract urothelial cancer","volume":"55","author":"Hisataki","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2012.08.009_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000050969","article-title":"Risk factors for the development of bladder transitional cell carcinoma following surgery for transitional cell carcinoma of the upper urinary tract","volume":"67","author":"Koga","year":"2001","journal-title":"Urol Int"},{"key":"10.1016\/j.clgc.2012.08.009_bib6","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/cncr.11691","article-title":"The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract","volume":"98","author":"Kang","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2012.08.009_bib7","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1097\/01.ju.0000144505.40915.98","article-title":"Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma","volume":"172","author":"Mullerad","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2012.08.009_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.urology.2004.09.021","article-title":"Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract","volume":"65","author":"Matsui","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2012.08.009_bib9","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1464-410X.2005.05804.x","article-title":"Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology","volume":"96","author":"Raman","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2012.08.009_bib10","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1158\/1078-0432.CCR-06-0825","article-title":"Chromosome 20q13.2 gain may predict intravesical recurrence after nephroureterectomy in upper urinary tract urothelial tumors","volume":"12","author":"Akao","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clgc.2012.08.009_bib11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000151409","article-title":"Identification of immunohistochemical factors that predict the synchronous or metachronous development of bladder tumors in patients with upper urinary tract tumors","volume":"81","author":"Joung","year":"2008","journal-title":"Urol Int"},{"key":"10.1016\/j.clgc.2012.08.009_bib12","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.eururo.2009.03.003","article-title":"Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan","volume":"55","author":"Kamihira","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2012.08.009_bib13","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.juro.2009.11.018","article-title":"Clinical epidemiology of nonurothelial bladder cancer: analysis of the Netherlands cancer registry","volume":"183","author":"Ploeg","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2012.08.009_bib14","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1002\/1097-0142(19881101)62:9<2016::AID-CNCR2820620924>3.0.CO;2-G","article-title":"Tumor grade and stage as prognostic variables in upper tract urothelial tumors","volume":"62","author":"Huben","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2012.08.009_bib15","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2012.08.009_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000296294","article-title":"Efficacy of adjuvant gemcitabine-cisplatin chemotherapy: A comparative study between locally advanced transitional cell carcinoma of the bladder and upper urinary tract","volume":"85","author":"Song","year":"2010","journal-title":"Urol Int"},{"key":"10.1016\/j.clgc.2012.08.009_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000092930","article-title":"Adjuvant chemotherapy in the management of pT3N0M0 transitional cell carcinoma of the upper urinary tract","volume":"77","author":"Lee","year":"2006","journal-title":"Urol Int"},{"key":"10.1016\/j.clgc.2012.08.009_bib18","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1200\/JCO.2004.09.043","article-title":"Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group","volume":"22","author":"Bamias","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2012.08.009_bib19","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1200\/JCO.2009.25.4599","article-title":"Prognostic factors in patients with advanced transitional cell carcinoma of the urothelial tract experiencing treatment failure with platinum-containing regimens","volume":"28","author":"Bellmunt","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2012.08.009_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.urolonc.2006.05.010","article-title":"Surgical benchmarks for the treatment of invasive bladder cancer","volume":"25","author":"Skinner","year":"2007","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2012.08.009_bib21","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1016\/j.juro.2009.02.021","article-title":"Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy","volume":"181","author":"Roscigno","year":"2009","journal-title":"J Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155876731200184X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155876731200184X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:22:45Z","timestamp":1761564165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155876731200184X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S155876731200184X"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2012.08.009","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upper Urinary Tract Transitional Cell Carcinoma: Is There a Best?","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2012.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}